CRISPR Therapeutics AG (CRSP) Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)
CRISPR Therapeutics AG (NASDAQ:CRSP) Morgan Stanley 20th Annual Global Healthcare Conference Call September 12, 2022 11:40 AM ET Company Participants Samarth Kulkarni - Chief Executive Officer Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn Okay, great. Thanks for joining us, everybody. I’m Terence Flynn, Morgan Stanley, pharma and biotech analyst, and we’re very pleased to be hosting CRISPR Therapeutics this morning. First, for important disclosures, please see the Morgan Stanley ...